The Nevada Prescription Monitoring Program (PMP) has executed a memorandum of understanding (MOU) to participate in NABP PMP InterConnect®, the system that facilitates securing sharing of PMP data across state lines. Fourteen states – Arizona, Connecticut, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, New Mexico, North Dakota, Ohio, South Carolina, South Dakota, and Virginia – have […]
Read More ›
United Parcel Service (UPS) agreed to forfeit $40 million in payments received from online entities illegally selling and distributing prescription drug products. UPS and the United States Attorney’s Office for the Northern District of California entered a non-prosecution agreement that also included the company’s commitment to develop a compliance program to ensure that illegal online […]
Read More ›
Through board of pharmacy inspections of compounding pharmacies and proposed laws to tighten requirements for compounding, states are taking action to help ensure the safety of compounded drugs, reports The Washington Post. The article highlights the ongoing Iowa nonresident compounding pharmacy inspection program, a program initiated in partnership with NABP. Any disciplinary actions resulting from […]
Read More ›
To protect the public health, Food and Drug Administration (FDA) should carefully consider using the exercise of enforcement discretion during drug shortages, urges NABP. The statement was part of the Association’s comments submitted to FDA in response to the establishment of the FDA Drug Shortages Task Force and Strategic Plan. In the comments, NABP also […]
Read More ›
Inspections of 30 entities engaged in compounding are underway by Food and Drug Administration (FDA) inspectors as part of the agency’s response to the 2012 meningitis outbreak linked to contaminated compounded injectable drugs. Facilities in 11 states have been inspected to date, and the agency plans to continue inspections over the next couple of months. […]
Read More ›
Aimed to reduce prescription drug abuse and diversion, legislation that would establish an expanded PMP in Pennsylvania is under consideration by state lawmakers. House Bill 317, introduced by state Representative Gene DiGirolamo, would establish the Pharmaceutical Accountability Monitoring System (PAMS) for tracking prescription controlled substance (CS) medications dispensed in the state. PAMS is intended to […]
Read More ›
NABP is pleased to announce that the South Dakota prescription drug monitoring program (PDMP) is the 12th prescription monitoring program (PMP) to deploy NABP PMP InterConnect®. South Dakota joins PMPs in Arizona, Connecticut, Indiana, Kansas, Kentucky, Michigan, New Mexico, North Dakota, Ohio, South Carolina, and Virginia, which have implemented use of the NABP InterConnect, giving […]
Read More ›
Pharmacists’ authority to vaccinate may be expanded in Wyoming under a bill (HB 94) that would allow pharmacists to prescribe and administer immunizations for individuals age seven and older. The bill specifies that to ensure patient safety and confidentially, immunizations must be administered in a private space and dedicated to the administration of immunizations. Pharmacists […]
Read More ›
NABP member boards of pharmacy are moving swiftly to implement the Compounding Action Plan initiated by state boards of pharmacy and NABP in November 2012. The plan includes continued collaboration on the Iowa nonresident inspection program, sharing of inspection results and related actions, and ongoing dialogue. Boards are also taking actions in their respective states […]
Read More ›
Pharmacies compounding sterile drug products for dispensing to patients in California would be required to obtain a license to engage in that practice under a bill (SB 294) introduced to the state’s senate on February 19, 2013. Under the bill, both resident and nonresident pharmacies that compound sterile products for dispensing or shipment into the […]
Read More ›